Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Erik van Munster
Observed names:
E. Van Munster,
E. van Munster,
Erik van Munster (341163)
Institution:
Jeroen Bosch Ziekenhuis
Observed institutions:
The Royal Melbourne Hospital,
The University of Melbourne,
Radboud University Medical Center,
University of Chieti-Pescara,
University Hospital,
Hôpital Charles-Le Moyne,
Hôpital Notre-Dame,
Jeroen Bosch Ziekenhuis
show all 8
OpenAlex ID:
A5085493799
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
2018
·
Raju Kapoor
, Pei-Ran Ho
, et al.
·
The Lancet Neurology
·
359
PDF
Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS
2015
·
Karen Ann Ribbons
, Patrick McElduff
, et al.
·
PLoS ONE
·
217
PDF
Persistence on Therapy and Propensity Matched Outcome Comparison of Two Subcutaneous Interferon Beta 1a Dosages for Multiple Sclerosis
2013
·
Tomas Kalincik
, Timothy Spelman
, et al.
·
PLoS ONE
·
136
Risk of relapse phenotype recurrence in multiple sclerosis
2014
·
Tomas Kalincik
, Katherine Buzzard
, et al.
·
Multiple Sclerosis Journal
·
121
PDF
Does aerobic training alleviate fatigue and improve societal participation in patients with multiple sclerosis? A randomized controlled trial
2017
·
Martin Heine
, Olaf Verschuren
, et al.
·
Multiple Sclerosis Journal
·
89
PDF
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients
2016
·
Gavin Giovannoni
, Jeffrey A. Cohen
, et al.
·
Neurology
·
67
PDF
Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse
2016
·
Peter Joseph Jongen
, Ioanna Stavrakaki
, et al.
·
Journal of Neurology
·
53
PDF
Contribution of different relapse phenotypes to disability in multiple sclerosis
2016
·
Tamasine Stewart
, Tim Spelman
, et al.
·
Multiple Sclerosis Journal
·
45
Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS
2016
·
Tim Spelman
, Tomas Kalincik
, et al.
·
Neurology Clinical Practice
·
42
PDF
Real-Time Assessment of Fatigue in Patients With Multiple Sclerosis: How Does It Relate to Commonly Used Self-Report Fatigue Questionnaires?
2016
·
Martin Heine
, Lizanne Eva van den Akker
, et al.
·
Archives of Physical Medicine and Rehabilitation
·
33
Adverse Events of Interferon Beta-1a: A Prospective Multi-Centre International ICH-GCP-Based CRO-Supported External Validation Study in Daily Practice
2011
·
Peter Joseph Jongen
, Christian Sindic
, et al.
·
PLoS ONE
·
17
PDF
SSEP chronotopography in patients with multiple sclerosis
2009
·
E. J. Colon
, E. Van Munster
, et al.
·
Acta Neurologica Scandinavica
·
5
Evaluation of common criteria of progression of disability in a large observational cohort
2014
·
Tomáš Kalinčík
, Vilija Jokubaitis
, et al.
·
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)
Seasonal variation of relapse rate and ultraviolet radiation levels are sinusoidal and their phase-shifted relationship is latitude-dependent
2012
·
Tim Spelman
, Orla Gray
, et al.
·
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)
Assessment of motor function in Multiple Sclerosis patients treated with Methylprednisolone
2011
·
Frank van Eijkeren
, R.S.J. Reijmers
, et al.
·
Indian Journal of Physiotherapy and Occupational Therapy - An International Journal
Show more works
View as search
Works count:
16
Citation count:
1,184
H-index:
11
I10-index:
11
Year
Topic
Type